Maintenance Therapy1
Gefitinib NSCLC maintenance therapy
Translational Lung Cancer Research
2012;
1
(2)
:94-95
.
(30 June 2012)
Biomarkers in the selection of maintenance therapy in non-small cell lung cancer
Translational Lung Cancer Research
2012;
1
(2)
:96-98
.
(30 June 2012)
A strong step forward in maintenance therapy for non-small cell lung cancer treatment
Translational Lung Cancer Research
2012;
1
(2)
:99-101
.
(30 June 2012)
INFORM; C-TONG 0805: A multicenter, double blind randomizedphase III trial of maintenance gefitinib compared to placebo inadvanced non-small cell lung cancer
Translational Lung Cancer Research
2012;
1
(2)
:102-104
.
(30 June 2012)
Maintenance therapy in non-small cell lung cancer
Translational Lung Cancer Research
2012;
1
(2)
:105-110
.
(30 June 2012)
Review Articles
From tissue to molecular phenotyping: Pre-analytical requirements
Translational Lung Cancer Research
2012;
1
(2)
:111-121
.
(30 June 2012)
Targeting angiogenesis in lung cancer-Pitfalls in drug development
Translational Lung Cancer Research
2012;
1
(2)
:122-128
.
(30 June 2012)
Original Article
Erlotinib in patients with advanced non-small-cell lung cancer: A meta-analysis
Translational Lung Cancer Research
2012;
1
(2)
:129-144
.
(30 June 2012)
Perspectives
EGFR IHC score for selection of cetuximab treatment: Ready for clinical practice?
Translational Lung Cancer Research
2012;
1
(2)
:145-146
.
(30 June 2012)
TKIs in NSCLC: The down of a new era?
Translational Lung Cancer Research
2012;
1
(2)
:147-148
.
(30 June 2012)
Treating acquired resistance to EGFR-tyrosine kinase inhibitors: Still a work in progress
Translational Lung Cancer Research
2012;
1
(2)
:149-151
.
(30 June 2012)
Is there a third line option after chemotherapy and TKI failure in advanced non-small cell lung cancer?
Translational Lung Cancer Research
2012;
1
(2)
:152-154
.
(30 June 2012)
Editorials
TRAIL apoptotic pathway-targeted therapies for NSCLC
Translational Lung Cancer Research
2012;
1
(2)
:155-157
.
(30 June 2012)
Dulanermin in cancer therapy: Still much to do
Translational Lung Cancer Research
2012;
1
(2)
:158-159
.
(30 June 2012)
EGFR TKIs as maintenance therapy in NSCLC: Finding the old in the new INFORMation
Translational Lung Cancer Research
2012;
1
(2)
:160-162
.
(30 June 2012)
Disclosure:
1. The series “Maintenance Therapy” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding.
